Correlation Between Relief Therapeutics and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Relief Therapeutics and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relief Therapeutics and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relief Therapeutics Holding and Scopus Biopharma, you can compare the effects of market volatilities on Relief Therapeutics and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relief Therapeutics with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relief Therapeutics and Scopus Biopharma.
Diversification Opportunities for Relief Therapeutics and Scopus Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Relief and Scopus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Relief Therapeutics Holding and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Relief Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relief Therapeutics Holding are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Relief Therapeutics i.e., Relief Therapeutics and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Relief Therapeutics and Scopus Biopharma
If you would invest (100.00) in Scopus Biopharma on December 5, 2024 and sell it today you would earn a total of 100.00 from holding Scopus Biopharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Relief Therapeutics Holding vs. Scopus Biopharma
Performance |
Timeline |
Relief Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Scopus Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Relief Therapeutics and Scopus Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Relief Therapeutics and Scopus Biopharma
The main advantage of trading using opposite Relief Therapeutics and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relief Therapeutics position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.Relief Therapeutics vs. Games Workshop Group | Relief Therapeutics vs. Ainsworth Game Technology | Relief Therapeutics vs. Bragg Gaming Group | Relief Therapeutics vs. GameSquare Holdings |
Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |